Contradictory results:  reduction in the symptoms of age-associated cardiac hypertrophy in old mice, increase in SMAD2- and SMAD3 phosphorylation in cardiomyocytes;  reversal of age-related skeletal muscle and stem cell dysfunction;  inhibition of skeletal muscle regeneration in rats. The gene discussed is SMAD2; the disease is cardiac hypertrophy.